NCT07109427Recruiting
Impact of an Electronic Health Record Maintenance Alert on PSA Screening Rates in a 10-Hospital Integrated Health System
Source: ClinicalTrials.gov · Last updated 19 Aug 2026
Brief summary (registry, in English)
\- The investigators propose a clinical trial to evaluate the impact of annual shared decision making for PSA screening, supported by system-level enhancements to promote evidence-based care: * Defined referral thresholds within the health maintenance reminder, aligned with clinical risk stratification per NCCN guidelines. * Enhanced clinical decision support (CDS) tools to reduce provider variation and ensure guideline-concordant screening and referral practices. * The goal is to reduce late-stage presentation without increasing overdiagnosis-ensuring that prostate cancer screening is both accessible and clinically effective.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 40000 (estimated)
- First submitted
- 31 Jul 2025
- Start date
- 11 Aug 2025
- Primary completion date
- 31 Aug 2031
- Lead sponsor
- Washington University School of Medicine
- Diseases
- Prostate cancer
- NCT number
- NCT07109427
What you commit to
- Study type: Interventional
- Planned participants: 40000
- From 11 Aug 2025 to the primary completion date, 31 Aug 2031
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Criteria the registry did not label
- Eligibility Criteria:
- Receive care within the BJC Health System
- Have had at least one primary care physician appointment in the calendar year of PSA screening (primary care)
- Be male
- Not have a history of prostate cancer
- Meet one of the following risk criteria:
- High Risk for Prostate Cancer
- African American, between the ages of 40 and 75 (inclusive), or
- Family history of prostate, breast, ovarian, and/or pancreatic cancer, or
- Known familial germline mutation OR
- Average Risk for Prostate Cancer
- Between the ages of 50 and 75 (inclusive)
Age in the registry: 40 years to 75 years · Sex: Male · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Washington University School of Medicine Coordinator of this site? Confirm its status | St Louis | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.